Mucoadhesive microspheres for nasal administration of cyclodextrins

References

• AJ Almeida, HO Alpar, and MR Brown. (1993). Immune response to nasal delivery of antigenically intact tetanus toxoid associated with poly(L-lactic acid) microspheres in rats, rabbits and guinea-pigs. J Pharm Pharmacol 45:198–203.
   PubMed Web of Science ®Google Scholar
• ME Aulton. (1988). Pharmaceutics: The science of dosage form design. Edinburgh/London/Melbourne/New York: Churchill Livingstone. p 566–567.
   Google Scholar
• C Baudin, C Pean, B Perly, and P Goselin. (2000). Inclusion of organic pollutants in cyclodextrin and derivatives. Int J Environ Anal Chem 77:233–242.
   Web of Science ®Google Scholar
• CR Behl, HK Pimplaskar, AP Sileno, J de Meireles, and VD Romeo. (1998). Effects of physicochemical properties and other factors on systemic nasal drug delivery. Adv Drug Deliv Rev 29:89–116.
   PubMed Web of Science ®Google Scholar
• DC Bibby, NM Davies, and IG Tucker. (2000). Mechanisms by which cyclodextrins modify drug release from polymeric drug delivery systems. Int J Pharm 197:1–11.
   PubMed Web of Science ®Google Scholar
• F Camargo, RP Erickson, WS Garver, GS Hossain, PN Carbone, RA Heidenreich, and J Blanchard. (2001). Cyclodextrins in the treatment of a mouse model of Niemann-Pick C disease. Life Sci 70:131–142.
   PubMed Web of Science ®Google Scholar
• P Camilleri, NJ Haskins, and DR Howlett. (1994). β-Cyclodextrin interacts with the Alzheimer amyloid β-A4 peptide. FEBS Lett 341:256–258.
   PubMed Web of Science ®Google Scholar
• T Cerchiara, B Luppi, G Chidichimo, F Bigucci, and V Zecchi. (2005). Chitosan and poly(methyl vinyl ether-co-maleic anhydride) microparticles as nasal sustained delivery systems. Eur J Pharm Biopharm 61:195–200.
   PubMed Web of Science ®Google Scholar
• ST Charlton, SS Davis, and L Illum. (2007a). Evaluation of bioadhesive polymers as delivery systems for nose to brain delivery: In vitro characterization studies. J Control Release 118:225–234.
   PubMed Web of Science ®Google Scholar
• S Charlton, NS Jones, SS Davis, and L Illum. (2007b). Distribution and clearance of bioadhesive formulations from the olfactory region in man: Effect of polymer type and nasal delivery device. Eur J Pharm Sci 30:295–302.
   PubMed Web of Science ®Google Scholar
• NYK Chew, P Tang, H-K Chan, and JA Raper. (2005). How much particle surface corrugation is sufficient to improve aerosol performance of powders?. Pharm Res 22:148–152.
   PubMed Web of Science ®Google Scholar
• HR Costantino, L Illum, G Brandt, PH Johnson, and SC Quaya. (2007). Intranasal delivery: Physicochemical and therapeutic aspects. Int J Pharm 337:1–24.
   PubMed Web of Science ®Google Scholar
• H Critchley, SS Davis, NF Farraj, and L Illum. (1994). Nasal absorption of desmopressin in rats and sheep. Effect of a bioadhesive microsphere delivery system. J Pharm Pharmacol 46:651–656.
   PubMed Web of Science ®Google Scholar
• A Dalpiaz, E Gavini, G Colombo, P Russo, F Bortolotti, L Ferraro, S Tanganelli, A Scatturin, E Menegatti, and P Giunchedi. (2008). Brain uptake of an anti-ischemic agent by nasal administration of microparticles. J Pharm Sci 97:4889–4903.
   PubMed Web of Science ®Google Scholar
• EMM Del Valle. (2004). Cyclodextrins and their uses: A review. Process Biochem 39:1033–1046.
   Web of Science ®Google Scholar
• RR Dubey, and RH Parikh. (2004). Studies of PLGA microspheres. Pharm Technol Eur 16:23–34.
   Google Scholar
• JE Eyles, GJ Sharp, ED Williamson, ID Spiers, and HO Alpar. (1998). Intranasal administration of poly-lactic acid microsphere co-encapsulated Yersinia pestis subunits confers protection from pneumonic plague in the mouse. Vaccine 16:698–707.
   PubMed Web of Science ®Google Scholar
• G Fundueanu, M Constantin, A Dalpiaz, F Bortolotti, R Cortesi, P Ascenzi, and E Menegatti. (2004). Preparation and characterization of starch/cyclodextrin bioadhesive microspheres as platform for nasal administration of Gabexate Mesylate (Foy) in allergic rhinitis treatment. Biomaterials 25:159–170.
   PubMed Web of Science ®Google Scholar
• E Gavini, G Rassu, V Sanna, M Cossu, and P Giunchedi. (2005). Mucoadhesive microspheres for nasal administration of an antiemetic drug, metoclopramide: In vitro/ex-vivo studies. J Pharm Pharmacol 57:287–294.
   PubMed Web of Science ®Google Scholar
• E Gavini, AB Hegge, G Rassu, V Sanna, C Testa, G Pirisino, J Karlsen, and P Giunchedi. (2006). Nasal administration of Carbamazepine using chitosan microspheres: In vitro/in vivo studies. Int J Pharm 307:9–15.
   PubMed Web of Science ®Google Scholar
• E Gavini, G Rassu, C Muzzarelli, M Cossu, and P Giunchedi. (2008). Spray-dried microspheres based on methylpyrrolidinone chitosan as new carrier for nasal administration of metoclopramide. Eur J Pharm Biopharm 68:245–252.
   PubMed Web of Science ®Google Scholar
• J Ghanta, C-L Shen, LL Kiessling, and M Murphy. (1999). A strategy for designing inhibitors of β-amyloid toxicity. J Biochem Chem 271:29525–29528.
   Google Scholar
• A Hafner, J Filipovic-Grcic, D Voinovich, and I Jalsenjak. (2007). Development and in vitro characterization of chitosan-based microspheres for nasal delivery of promethazine. Drug Dev Ind Pharm 33:427–436.
   PubMed Web of Science ®Google Scholar
• S Harikarnpakdee, V Lipipun, N Sutanthavibul, and GC Ritthidej. (2006). Spray-dried mucoadhesive microspheres: Preparation and transport through nasal cell monolayer. AAPS Pharm Sci Tech 10:E12.
   Google Scholar
• RA Hedges. (1998). Industrial applications of cyclodextrins. Chem Rev 98:2035–2044.
   PubMed Web of Science ®Google Scholar
• AM Hillary, AW Lloyd, and J Swarbrick. (2001). Drug delivery and targeting. London: Taylor & Francis. p 237–268.
   Google Scholar
• L Illum. (2002). Nasal drug delivery: New developments and strategies. Drug Discov Today 7:1184–1189.
   PubMed Web of Science ®Google Scholar
• L Illum. (2003). Nasal drug delivery-possibilities, problems and solutions. J Control Release 87:187–198.
   PubMed Web of Science ®Google Scholar
• L Illum. (2004). Is nose-to-brain transport of drugs in man a reality?. J Pharm Pharmacol 56:3–17.
   PubMed Web of Science ®Google Scholar
• L Illum, AN Fisher, I Jabbal-Gill, and SS Davis. (2001a). Bioadhesive starch microspheres and absorption enhancing agents act synergistically to enhance the nasal absorption of polypeptides. Int J Pharm 222:109–119.
   PubMed Web of Science ®Google Scholar
• L Illum, I Jabbal-Gill, M Hinchcliffe, AN Fisher, and SS Davis. (2001b). Chitosan as a novel nasal delivery system for vaccines. Adv Drug Deliv Rev 51:81–96.
   PubMed Web of Science ®Google Scholar
• L Illum, P Watts, AN Fisher, M Hinchcliffe, H Norbury, I Jabbal-Gill, R Nankervis, and SS Davis. (2002). Intranasal delivery of morphine. J Pharmacol Exp Ther 301:391–400.
   PubMed Web of Science ®Google Scholar
• SK Jain, MK Chourasia, AK Jain, RK Jain, and AK Shrivastava. (2004). Development and characterization of mucoadhesive microspheres bearing salbutamol for nasal delivery. Drug Deliv 11:113–122.
   PubMed Web of Science ®Google Scholar
• R Koukiekolo, V Desseaux, Y Moreau, MG Marchis, and M Santimonie. (2001). Mechanism of porcine pancreatic alpha-amylase inhibition of amylose and maltopentaose hydrolysis by alpha-, beta- and gammacyclodextrins. Eur J Biochem 268:841–848.
   PubMedGoogle Scholar
• R Kumar, JS Dahiya, D Singh, and P Nigam. (2001). Biotransformation of cholesterol using Lactobacillus bulgaricus in glucose controlledbioreactor. Bioresour Technol 28:209–211.
   Google Scholar
• ST Lim, GP Martin, DJ Berry, and MB Brown. (2000). Preparation and evaluation of the in vitro drug release properties and mucoadhesion of novel microspheres of hyaluronic acid and chitosan. J Control Release 66:281–292.
   PubMed Web of Science ®Google Scholar
• T Loftsson, and ME Brewster. (1996). Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J Pharm Sci 85:1017–1024.
   PubMed Web of Science ®Google Scholar
• S Lowell, and JE Shields. (1998). Powder surface area and porosity. 3rd ed. London: Chapman & Hall. p 3–6.
   Google Scholar
• X Lu, and Y Chen. (2002). Chiral separation of amino acids derivatized with fluoresceine-5-isothiocyanate by capillary electrophoresis and laserinduced fluorescence detection using mixed selectors of beta-cyclodextrin and sodium taurocholate. J Chromatogr A 955:133–140.
   PubMed Web of Science ®Google Scholar
• A Martinac, J Filipovic-Grcic, D Voinovich, B Perissutti, and E Franceschinis. (2005). Development and bioadhesive properties of chitosan-ethylcellulose microspheres for nasal delivery. Int J Pharm 291:69–77.
   PubMed Web of Science ®Google Scholar
• L Pereswetoff-Morath. (1998). Microspheres as nasal drug delivery systems. Adv Drug Deliv Rev 29:185–194.
   PubMed Web of Science ®Google Scholar
• M Prior, S Lehmann, MS Sy, B Molloy, and HE McMahon. (2007). Cyclodextrins inhibit replication of scrapie prion protein in cell culture. J Virol 81:11195–11207.
   PubMed Web of Science ®Google Scholar
• X Qin, H Abe, and H Nakanishi. (2002). NMR and CD studies on the interaction of Alzheimer β-amyloid peptide (12–28) with β-cyclodextrin. Biochem Biophys Res Commun 297:1011–1015.
   PubMed Web of Science ®Google Scholar
• PS Rajinikanth, C Sankar, and B Mishra. (2003). Sodium alginate microspheres of metoprolol tartrate for intranasal systemic delivery: Development and evaluation. Drug Deliv 10:21–28.
   PubMed Web of Science ®Google Scholar
• C Sankar, M Rani, AK Srivastava, and B Mishra. (2001). Chitosan based pentazocine microspheres for intranasal systemic delivery: Development and biopharmaceutical evaluation. Pharmazie 56:223–226.
   PubMed Web of Science ®Google Scholar
• RJ Soane, M Hinchcliffe, SS Davis, and L Illum. (2001). Clearance characteristics of chitosan based formulations in the sheep nasal cavity. Int J Pharm 217:183–191.
   PubMed Web of Science ®Google Scholar
• M Tafaghodi, SAS Tabassi, MR Jaafari, SR Zakavi, and M Momen-nejad. (2004). Evaluation of the clearance characteristics of various microspheres in the human nose by gamma-scintigraphy. Int J Pharm 280:125–135.
   PubMed Web of Science ®Google Scholar
• WE Trevelyan, and JS Harrison. (1952). Studies on yeast metabolism. 1. Fractionating and microdetermination of cell carbohydrates. Biochem J 50:298–303.
   PubMed Web of Science ®Google Scholar
• S Türker, E Onur, and Y Ozer. (2004). Nasal route and drug delivery systems. Pharm World Sci 26:137–142.
   PubMed Web of Science ®Google Scholar
• MI Ugwoke, RU Agu, N Verbeke, and R Kinget. (2005). Nasal mucoadhesive drug delivery: Background, applications, trends and future perspectives. Adv Drug Deliv Rev 57:1640–1665.
   PubMed Web of Science ®Google Scholar